Role of peroxisome proliferator-activated receptor-α in fasting-mediated oxidative stress

Free Radical Biology and Medicine

Volumn 47, Issue 6, 2009, Pages 767-778

  Abdelmegeed, Mohamed A ^a   Moon, Kwan Hoon ^a   Hardwick, James P ^b   Gonzalez, Frank J ^c   Song, Byoung Joon ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aldehyde dehydrogenase; Fasting; Lipid peroxidation; Liver; Null mice; Oxidative stress; PPAR ; Protein nitration; Protein oxidation; Steatosis; Superoxide dismutase

Indexed keywords

GLUTATHIONE; HYDROGEN PEROXIDE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; FATTY LIVER; FEMALE; INFLAMMATION; LIPID PEROXIDATION; MOUSE; NITRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; FASTING; FATTY LIVER; GLUTATHIONE; HYDROGEN PEROXIDE; LIPID PEROXIDATION; LIVER; MICE; MICE, KNOCKOUT; MITOCHONDRIA, LIVER; NITRIC OXIDE SYNTHASE; NITRO COMPOUNDS; OXIDATIVE STRESS; PPAR ALPHA; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 68349131724     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.06.017     Document Type: Article

References (64)

1. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., Umesono K., and Evans R.M. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91 (1994) 7355-7359
2. Braissant O., Foufelle F., Scotto C., Dauca M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137 (1996) 354-366
3. Greene M.E., Blumberg B., McBride O.W., Yi H.F., Kronquist K., Kwan K., Hsieh L., Greene G., and Nimer S.D. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr. 4 (1995) 281-299
4. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
5. Mandard S., Muller M., and Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci. 61 (2004) 393-416
6. Poirier H., Niot I., Monnot M.C., Braissant O., Meunier-Durmort C., Costet P., Pineau T., Wahli W., Willson T.M., and Besnard P. Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine. Biochem. J. 355 (2001) 481-488
7. Rodriguez J.C., Gil-Gomez G., Hegardt F.G., and Haro D. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem. 269 (1994) 18767-18772
8. Aoyama T., Peters J.M., Iritani N., Nakajima T., Furihata K., Hashimoto T., and Gonzalez F.J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 273 (1998) 5678-5684
9. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498
10. Leone T.C., Weinheimer C.J., and Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96 (1999) 7473-7478
11. Hashimoto T., Cook W.S., Qi C., Yeldandi A.V., Reddy J.K., and Rao M.S. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J. Biol. Chem. 275 (2000) 28918-28928
12. Lee S.S., Chan W.Y., Lo C.K., Wan D.C., Tsang D.S., and Cheung W.T. Requirement of PPARalpha in maintaining phospholipid and triacylglycerol homeostasis during energy deprivation. J. Lipid Res. 45 (2004) 2025-2037
13. Hong J.Y., Pan J.M., Gonzalez F.J., Gelboin H.V., and Yang C.S. The induction of a specific form of cytochrome P-450 (P-450j) by fasting. Biochem. Biophys. Res. Commun. 142 (1987) 1077-1083
14. Brown B.L., Allis J.W., Simmons J.E., and House D.E. Fasting for less than 24 h induces cytochrome P450 2E1 and 2B1/2 activities in rats. Toxicol. Lett. 81 (1995) 39-44
15. Marczuk-Krynicka D., Hryniewiecki T., Piatek J., and Paluszak J. The effect of brief food withdrawal on the level of free radicals and other parameters of oxidative status in the liver. Med. Sci. Monit. 9 (2003) BR131-BR135
16. Sorensen M., Sanz A., Gomez J., Pamplona R., Portero-Otin M., Gredilla R., and Barja G. Effects of fasting on oxidative stress in rat liver mitochondria. Free Radic. Res. 40 (2006) 339-347
17. Bauer M., Hamm A.C., Bonaus M., Jacob A., Jaekel J., Schorle H., Pankratz M.J., and Katzenberger J.D. Starvation response in mouse liver shows strong correlation with life-span-prolonging processes. Physiol. Genomics 17 (2004) 230-244
18. Begriche K., Igoudjil A., Pessayre D., and Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6 (2006) 1-28
19. Letteron P., Fromenty B., Terris B., Degott C., and Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J. Hepatol. 24 (1996) 200-208
20. Leclercq I.A., Farrell G.C., Field J., Bell D.R., Gonzalez F.J., and Robertson G.R. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J. Clin. Invest. 105 (2000) 1067-1075
21. Catala A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 157 (2009) 1-11
22. Fujita K., Nozaki Y., Yoneda M., Wada K., Takahashi H., Kirikoshi H., Inamori M., Saito S., Iwasaki T., Terauchi Y., Maeyama S., and Nakajima A. Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, L-amino acid-defined diet-fed rat model. Alcohol. Clin. Exp. Res. 33 (2008) 1-7 (Suppl 1; No. S1)
23. Stienstra R., Mandard S., Patsouris D., Maass C., Kersten S., and Muller M. Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation. Endocrinology 148 (2007) 2753-2763
24. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., and Gonzalez F.J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15 (1995) 3012-3022
25. Suh S.K., Hood B.L., Kim B.J., Conrads T.P., Veenstra T.D., and Song B.J. Identification of oxidized mitochondrial proteins in alcohol-exposed human hepatoma cells and mouse liver. Proteomics 4 (2004) 3401-3412
26. Bae M.A., and Song B.J. Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells. Mol. Pharmacol. 63 (2003) 401-408
27. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 278 (2003) 36027-36031
28. Moon K.H., Upreti V.V., Yu L.R., Lee I.J., Ye X., Eddington N.D., Veenstra T.D., and Song B.J. Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics 8 (2008) 3906-3918
29. Reinke L.A., and Moyer M.J. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab. Dispos. 13 (1985) 548-552
30. Kim B.J., Ryu S.W., and Song B.J. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J. Biol. Chem. 281 (2006) 21256-21265
31. Moon K.H., Hood B.L., Mukhopadhyay P., Rajesh M., Abdelmegeed M.A., Kwon Y.I., Conrads T.P., Veenstra T.D., Song B.J., and Pacher P. Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 135 (2008) 1344-1357
32. Moon K.H., Abdelmegeed M.A., and Song B.J. Inactivation of cytosolic aldehyde dehydrogenase via S-nitrosylation in ethanol-exposed rat liver. FEBS Lett. 581 (2007) 3967-3972
33. Moon K.H., Hood B.L., Kim B.J., Hardwick J.P., Conrads T.P., Veenstra T.D., and Song B.J. Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology 44 (2006) 1218-1230
34. Novak R.F., and Woodcroft K.J. The alcohol-inducible form of cytochrome P450 (CYP2E1): role in toxicology and regulation of expression. Arch. Pharm. Res. 23 (2000) 267-282
35. Caro A.A., and Cederbaum A.I. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 27-42
36. Yun Y.P., Casazza J.P., Sohn D.H., Veech R.L., and Song B.J. Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet. Mol. Pharmacol. 41 (1992) 474-479
37. Song B.J., Moon K.H., Olsson N.U., and Salem Jr. N. Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J. Hepatol. 49 (2008) 262-273
38. Mantena S.K., King A.L., Andringa K.K., Eccleston H.B., and Bailey S.M. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic. Biol. Med. 44 (2008) 1259-1272
39. Mantena S.K., Vaughn D.P., Andringa K.K., Eccleston H.B., King A.L., Abrams G.A., Doeller J.E., Kraus D.W., Darley-Usmar V.M., and Bailey S.M. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem. J. 417 (2009) 183-193
40. Yamakura F., Taka H., Fujimura T., and Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J. Biol. Chem. 273 (1998) 14085-14089
41. Gonzalez F.J., and Shah Y.M. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators. Toxicology 246 (2008) 2-8
42. Yu S., Rao S., and Reddy J.K. Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr. Mol. Med. 3 (2003) 561-572
43. Hardwick J.P. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metablic diseases. Biochem. Pharmacol. 75 (2008) 2263-2275
44. Zern M.A., Leo M.A., Giambrone M.A., and Lieber C.S. Increased type I procollagen mRNA levels and in vitro protein synthesis in the baboon model of chronic alcoholic liver disease. Gastroenterology 89 (1985) 1123-1131
45. Shimojo N. Cytochrome P450 changes in rats with streptozocin-induced diabetes. Int. J. Biochem. 26 (1994) 1261-1268
46. Abdelmegeed M.A., Carruthers N.J., Woodcroft K.J., Kim S.K., and Novak R.F. Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 315 (2005) 203-213
47. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
48. Barnett C.R., Abbott R.A., Bailey C.J., Flatt P.R., and Ioannides C. Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes. Biochem. Pharmacol. 43 (1992) 1868-1871
49. Halliwell B., Gutteridge J.M., and Cross C.E. Free radicals, antioxidants, and human disease: where are we now?. J. Lab. Clin. Med. 119 (1992) 598-620
50. Yu B.P. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74 (1994) 139-162
51. Takahashi M., Tsuboyama-Kasaoka N., Nakatani T., Ishii M., Tsutsumi S., Aburatani H., and Ezaki O. Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production. Am. J. Physiol.: Gasterointest. Liver Physiol. 282 (2002) G338-G348
52. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA 101 (2004) 4003-4008
53. Garcia-Ruiz I., Rodriguez-Juan C., Diaz-Sanjuan T., del Hoyo P., Colina F., Munoz-Yague T., and Solis-Herruzo J.A. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 44 (2006) 581-591
54. Quint P., Reutzel R., Mikulski R., McKenna R., and Silverman D.N. Crystal structure of nitrated human manganese superoxide dismutase: mechanism of inactivation. Free Radic. Biol. Med. 40 (2006) 453-458
55. Souza J.M., Choi I., Chen Q., Weisse M., Daikhin E., Yudkoff M., Obin M., Ara J., Horwitz J., and Ischiropoulos H. Proteolytic degradation of tyrosine nitrated proteins. Arch. Biochem. Biophys. 380 (2000) 360-366
56. Elfering S.L., Haynes V.L., Traaseth N.J., Ettl A., and Giulivi C. Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) H22-H29
57. Gow A.J., Duran D., Malcolm S., and Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett. 385 (1996) 63-66
58. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87 (2007) 315-424
59. Farres J., Wang T.T., Cunningham S.J., and Weiner H. Investigation of the active site cysteine residue of rat liver mitochondrial aldehyde dehydrogenase by site-directed mutagenesis. Biochemistry 34 (1995) 2592-2598
60. Hartley D.P., Ruth J.A., and Petersen D.R. The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase. Arch. Biochem. Biophys. 316 (1995) 197-205
61. Doorn J.A., Hurley T.D., and Petersen D.R. Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal. Chem. Res. Toxicol. 19 (2006) 102-110
62. You M., Fischer M., Cho W.K., and Crabb D. Transcriptional control of the human aldehyde dehydrogenase 2 promoter by hepatocyte nuclear factor 4: inhibition by cyclic AMP and COUP transcription factors. Arch. Biochem. Biophys. 398 (2002) 79-86
63. Anderson S.P., Howroyd P., Liu J., Qian X., Bahnemann R., Swanson C., Kwak M.K., Kensler T.W., and Corton J.C. The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. J. Biol. Chem. 279 (2004) 52390-52398
64. Shankar K., Vaidya V.S., Corton J.C., Bucci T.J., Liu J., Waalkes M.P., and Mehendale H.M. Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity. FASEB J. 17 (2003) 1748-1750